Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline
The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Abstract
OBJECTIVE The aim was to update The Endocrine Society Clinical Practice Guideline on Evaluation and Treatment of Adult Growth Hormone Deficiency (GHD) previously published in 2006. CONSENSUS PROCESS Consensus was guided by systematic reviews of evidence and discussions through a series of conference calls and e-mails. An initial draft was prepared by the Task Force, with the help of a medical writer, and reviewed and commented on by members of The Endocrine Society. A second draft was reviewed and approved by The Endocrine Society Council. At each stage of review, the Task Force received written comments and incorporated substantive changes. CONCLUSIONS GHD can persist from childhood or be newly acquired. Confirmation through stimulation testing is usually required unless there is a proven genetic/structural lesion persistent from childhood. GH therapy offers benefits in body composition, exercise capacity, skeletal integrity, and quality of life measures and is most likely to benefit those patients who have more severe GHD. The risks associated with GH treatment are low. GH dosing regimens should be individualized. The final decision to treat adults with GHD requires thoughtful clinical judgment with a careful evaluation of the benefits and risks specific to the individual.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GHD in particular has a wide range of test methodology and diagnostic thresholds employed across studies, despite agreement among global guidelines [26 · , 64-67] as to what constitutes deficiency.”
From Neuroendocrine Disruptions Following Head Injury (2023) · cites this paper as [65]
In the citing paper
“For the diagnosis of TBI-induced GHD, the ITT and the GHRHϩARG test are now considered as the tests of choice with similar accuracy (194,215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“The glucagon stimulation test (GST) (1 mg glucagon im, GH measurements every 30 min until 240 min after administration) has been proposed as an alternative diagnostic because it is able to differentiate between GH-deficient and healthy subjects with a sensitivity and specificity of 100% if a peak GH of 3 g/L is considered (215, 226).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“For the ITT, peak GH response levels lower than 3 g/L indicate severe GHD in adults (if hypoglycemia is adequately reached) (194,215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“Therefore, in the latest Endocrine Society guideline on the evaluation and treatment of adult GHD, as part of their standard clinical care, patients with severe GHD (diagnosed by appropriate dynamic tests and with relevant clinical features) were recommended individualized physiological doses of recombinant GH treatment (215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Gamma knife radiosurgery for trigeminal neuralgia associated with multiple sclerosis
Rogers, L., Shetter, A. G., Ponce, F. A., Fiedler, J. A., Smith, K. A., & Speiser, B. L. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.97.supplement_5.0529 · Cited by 1,773
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402 · cited 1×
“hypogonadal men received testosterone replacement (154).”
Salomon, F., Cuneo, R. C., Hesp, R., & Sönksen, P. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212605 · Cited by 1,326
The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events
Hodis, H. N., Mack, W. J., LaBree, L., Selzer, R. H., Liu, C.-R., Liu, C.-H., & Azen, S. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-4-199802150-00002 · Cited by 1,217 · cited 1×
“In epidemiological studies, increases in IMT have predicted the development of symptomatic coronary disease occurring approximately 8 yr after the initial measurements (137).”
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS
Jørgensen, J. O. L., Thuesen, L., Ingemann-Hansen, T., Pedersen, S. A., Jørgensen, I., Skakkebaek, N. E., & Christiansen, J. S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92328-3 · Cited by 890
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822
Self-citationTreatment of adults with growth hormone (GH) deficiency with recombinant human GH.
Bengtsson, B. A., Edén, S., Lönn, L., Kvist, H., Stokland, A., Lindstedt, G., Bosaeus, I., Tölli, J., Sjöström, L., & Isaksson, O. G. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432773 · Cited by 778
Clinical Aspects of Growth Hormone Deficiency in Adults
BOER, H. D., BLOK, G.-J., & DER VEEN, E. A. V. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-63 · Cited by 723
Cited by
Items 201–300 of 1,000
Endocrine aspects and sequel in patients with craniopharyngioma
Erfurth, E. M. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0419 · Cited by 40
Kim, J. H., Chae, H. W., Chin, S. O., Ku, C. R., Park, K. H., Lim, D. J., Kim, K. J., Lim, J. S., Kim, G., Choi, Y. M., et al. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.35.2.272 · Cited by 52
Boguszewski, M. C. D. S., Cardoso-Demartini, A. D. A., Boguszewski, C. L., Chemaitilly, W., Higham, C., Johannsson, G., & Yuen, K. C. J. (2021) · Pituitary · doi:10.1007/s11102-021-01173-0 · Cited by 47
Rasmussen, M. H., Bysted, B. V., Anderson, T. W., Klitgaard, T., & Madsen, J. C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2813 · Cited by 43
Boot, A. M., van der Sluis, I. M., Krenning, E. P., & Keizer‐Schrama, S. M. P. F. D. M. (2009) · Hormone Research in Paediatrics · doi:10.1159/000223422 · Cited by 44
Flatt, M. A., Settersten, R. A., Ponsaran, R., & Fishman, J. R. (2013) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbt086 · Cited by 49
Kołtowska-Häggström, M., Geffner, M. E., Jönsson, P., Monson, J. P., Abs, R., Hána, V., Höybye, C., & Wollmann, H. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2013 · Cited by 32
Growth hormone deficiency and NAFLD: An overlooked and underrecognized link
Doycheva, I., Erickson, D. Z., & Watt, K. D. S. (2022) · Hepatology Communications · doi:10.1002/hep4.1953 · Cited by 38
Determination of IGFs and their binding proteins
Hjortebjerg, R., & Frystyk, J. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.08.010 · Cited by 41
Wright, T., Urban, R., Durham, W., Dillon, E. L., Randolph, K. M., Danesi, C., Gilkison, C., Karmonik, C., Zgaljardic, D. J., Masel, B., et al. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2019.6690 · Cited by 39
Pituitary Physiology and Diagnostic Evaluation
Kaiser, U. B., & Ho, K. K. Y. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00008-3 · Cited by 49
Johannsson, G., & Ragnarsson, Ó. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13382 · Cited by 46
Carosi, G., Brunetti, A., Mangone, A., Baldelli, R., Tresoldi, A. S., Sindaco, G. D., Lavezzi, E., Sala, E., Mungari, R., Fatti, L. M., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.925378 · Cited by 46
Javed, Z., Qamar, U., & Sathyapalan, T. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.167561 · Cited by 43
Diagnosing Growth Hormone Deficiency in Adults
Glynn, N., & Agha, A. (2012) · International Journal of Endocrinology · doi:10.1155/2012/972617 · Cited by 44
Newman, C. B., Carmichael, J. D., & Kleinberg, D. L. (2014) · Pituitary · doi:10.1007/s11102-014-0571-z · Cited by 42
“For those reasons, lower fixed doses of GH are now employed [7].”
BackgroundInfluentialRasmussen, M. H., Janukonyté, J., Klose, M., Marina, D., Tanvig, M. H., Nielsen, L. F., Höybye, C., Andersen, M., Feldt‐Rasmussen, U., & Christiansen, J. S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1991 · Cited by 42
Weber, M. M., Biller, B. M. K., Pedersen, B. T., Pournara, E., Christiansen, J. S., & Höybye, C. (2016) · Clinical Endocrinology · doi:10.1111/cen.13256 · Cited by 42
Barake, M., Arabi, A., Nakhoul, N., Fuleihan, G. E., Ghandour, S. E., Klibanski, A., & Tritos, N. A. (2017) · Endocrine · doi:10.1007/s12020-017-1440-0 · Cited by 40
Otsuka, F., Takahashi, Y., Tahara, S., Ogawa, Y., Rasmussen, M. H., & Takano, K. (2020) · Clinical Endocrinology · doi:10.1111/cen.14273 · Cited by 38
Management of growth hormone deficiency in adults
Nilsson, A. G., Svensson, J., & Johannsson, G. (2007) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2007.05.005 · Cited by 43
Adult growth hormone deficiency: clinical advances and approaches to improve adherence
Yuen, K. C. J., Llahana, S., & Miller, B. S. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1689119 · Cited by 41
“Macimorelin was subsequently compared to the ITT in a multicenter, openlabel, randomized, two-way crossover study [36], and was found to be a simple, highly reproducible, and safe test, with optimal GH cut-points ranging from 4.6 to 8.1 μg/L.”
BackgroundMethodInfluentialRetesting the childhood-onset GH-deficient patient
Gasco, V., Corneli, G., Beccuti, G., Prodam, F., Rovere, S., BELLONE, J., Grottoli, S., Aimaretti, G., & Ghigo, E. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0293 · Cited by 41
Production of recombinant mink growth hormone in E. coli
Sereikaitė, J., Statkute, A., Morkūnas, M., Radzevičius, K., Borromeo, V., Secchi, C., & Bumelis, V. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-006-0673-2 · Cited by 37
Casano‐Sancho, P., Suárez, L., Ibáñez, L., García‐Fructuoso, G., Medina, J., & Febrer, A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12237 · Cited by 36
Pituitary dysfunction due to sports-related traumatic brain injury
Hacioglu, A., Kelestimur, F., & Tanriverdi, F. (2019) · Pituitary · doi:10.1007/s11102-019-00937-z · Cited by 36
Savastano, S., Somma, C. D., Colao, A., Barrea, L., Orio, F., Finelli, C., Pasanisi, F., Contaldo, F., & Tarantino, G. (2014) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2014.10.006 · Cited by 35
“Low GH secretion [22] and low IGF-1 levels [23] were defined using pre-determined cutoff-points.”
MethodTanrıverdi, F., Bellis, A. D., Teksahin, H., Alp, E., Bizzarro, A., Sinisi, A. A., Bellastella, G., Paglionico, V. A., Bellastella, A., Unluhizarci, K., et al. (2012) · Pituitary · doi:10.1007/s11102-011-0371-7 · Cited by 37
Hypopituitarism in Traumatic Brain Injury—A Critical Note
Klose, M., & Feldt-Rasmussen, U. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4071480 · Cited by 36
ENDOCRINOLOGY AND ADOLESCENCE: Dealing with transition in young patients with pituitary disorders
Sbardella, E., Pozza, C., Isidori, A. M., & Grossman, A. B. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0298 · Cited by 40
Diagnosis of GH Deficiency as a Late Effect of Radiotherapy in Survivors of Childhood Cancers
Sfeir, J. G., Kittah, N. E. N., Tamhane, S. U., Jasim, S., Chemaitilly, W., Cohen, L. E., & Murad, M. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01204 · Cited by 35
The Concept of Growth Hormone Deficiency Affecting Clinical Prognosis in IVF
Yovich, J. L., Regan, S. L. P., Zaidi, S. N. S. J. H., & Keane, K. N. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00650 · Cited by 36
“The final decision to treat adults with GHD requires thoughtful clinical judgment with a careful evaluation of the benefits and risks specific to the individual” (17).”
BackgroundPereira, R. M. C., Aguiar-Oliveira, M. H., Sagazio, A., Oliveira, C. R. P., Oliveira, F. T., Campos, V. C., Farias, C. T., Vicente, T. A. R., Gois, M. B., Oliveira, J. L. M., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0092 · Cited by 35
Zuhur, S. S., Kuzu, İ., Uysal, E., & Altuntaş, Y. (2014) · Turkish Neurosurgery · doi:10.5137/1019-5149.jtn.8671-13.0 · Cited by 35
Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia
Molitch, M. E. (2007) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70239-7 · Cited by 36
Self-citationAge-Related Hormones Changes and Its Impact on Health Status and Lifespan
Biagetti, B., & Puig‐Domingo, M. (2023) · Aging and Disease · doi:10.14336/ad.2022.1109 · Cited by 49
From liver to hormones: The endocrine consequences of cirrhosis
Aldave, J. E. Q., Osorio, E. R. G., Durand‐Vásquez, M. D. C., Rafael-Robles, L. D. P., Yovera, J. G. G., Quispe-Flores, M. A., Urteaga, L. A. C., Román-Gonzaléz, A., Paz‐Ibarra, J., & Concepción‐Zavaleta, M. J. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i9.1073 · Cited by 45
Classification of Patients With GH Disorders May Vary According to the IGF-I Assay
Mavromati, M., Kuhn, E., Agostini, H., Brailly‐Tabard, S., Massart, C., Piketty, M., Arnoux, A., Young, J., Souberbielle, J., & Chanson, P. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00202 · Cited by 34
Irwig, M. S., Fleseriu, M., Jonklaas, J., Tritos, N. A., Yuen, K. C. J., Correa, R. R., Elhomsy, G. C., Garla, V. V., Jasim, S., Soe, K. K., et al. (2020) · Endocrine Practice · doi:10.4158/ps-2019-0540 · Cited by 40
“In that adult population, GH replacement has been shown to induce beneficial effects on body composition, bone mineral density, serum lipids, exercise capacity, and quality of life (49,52).”
BackgroundResultInfluentialKubo, H., Sawada, S., Satoh, M., Asai, Y., Kodama, S., Sato, T., Tomiyama, S., Seike, J., Takahashi, K., Kaneko, K., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-23521-1 · Cited by 40
Phelan, N., Conway, S. H., Llahana, S., & Conway, G. S. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04277.x · Cited by 34
Höybye, C., Ragnarsson, O., Jönsson, P. J., Koltowska-Häggström, M., Trainer, P., Feldt-Rasmussen, U., & Biller, B. M. K. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0836 · Cited by 34
The value of IGF1 estimation in adults with GH deficiency
Mukherjee, A., & Shalet, S. M. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0247 · Cited by 36
Ramos-Levi, A. M., & Marazuela, M. (2018) · Endocrine · doi:10.1007/s12020-017-1492-1 · Cited by 35
Juul, R. V., Rasmussen, M. H., Agersø, H., & Overgaard, R. V. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0662-5 · Cited by 34
Growth hormone deficiency in treated acromegaly
Mazziotti, G., Marzullo, P., Doga, M., Aimaretti, G., & Giustina, A. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.10.005 · Cited by 33
Impact of adult growth hormone deficiency on daily functioning and well-being
Brod, M. I., Pohlman, B., Højbjerre, L., Adalsteinsson, J. E., & Rasmussen, M. H. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-813 · Cited by 33
Diagnosis and treatment of pediatric osteoporosis
Bachrach, L. K. (2014) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000106 · Cited by 36
Easypod™ a new electronic injection device for growth hormone
Dahlgren, J. (2008) · Expert Review of Medical Devices · doi:10.1586/17434440.5.3.297 · Cited by 33
Sensitivity and specificity of the macimorelin test for diagnosis of AGHD
Garcia, J. M., Biller, B. M. K., Korbonits, M., POPOVIC, V. M., Luger, A., Strasburger, C. J., Chanson, P., Swerdloff, R. S., Wang, C., Fleming, R. R., et al. (2020) · Endocrine Connections · doi:10.1530/ec-20-0491 · Cited by 38
Profka, E., Giavoli, C., Bergamaschi, S., Ferrante, E., Malchiodi, E., Sala, E., Verrua, E., Rodari, G., Filopanti, M., Beck‐Peccoz, P., et al. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0196-0 · Cited by 37
Fideleff, H. L., Boquete, H., Stalldecker, G., Giaccio, A., & Sobrado, P. G. V. (2008) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2008.01.002 · Cited by 34
Kay, R. G., Halsall, D. J., Annamalai, A. K., Kandasamy, N., Taylor, K., Fenwick, S., Webb, A., Wark, G., Pleasance, S., & Gurnell, M. (2012) · Clinical Endocrinology · doi:10.1111/cen.12085 · Cited by 34
Cenci, M. C. P., Conceição, F. L., Soares, D. V., Spina, L. D. C., Brasil, R. R. L. O., Lobo, P. M., Micmacher, E., & Vaisman, M. (2007) · Metabolism · doi:10.1016/j.metabol.2007.08.015 · Cited by 34
Rubeck, K. Z., Bertelsen, S., Vestergaard, P. F., & Jørgensen, J. O. L. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03592.x · Cited by 35
GH and Pituitary Hormone Alterations After Traumatic Brain Injury
Karaca, Z., Tanrıverdi, F., Ünlühızarcı, K., & Keleştimur, F. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.10.010 · Cited by 37
Yuen, K. C. J., Mattsson, A. F., Burman, P., Erfurth, E.-M., Camacho-Hubner, C., Fox, J. L., Verhelst, J., Geffner, M. E., & Abs, R. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01542 · Cited by 33
“All patients included in the current study had confirmed diagnosis of severe GHD by GH stimulation testing or had at least three pituitary hormone deficiencies and a low serum insulinlike growth factor I (IGF-I) standard deviation score (SDS),22, in accordance with current clinical practice guidelines (18, 19).”
MethodHypopituitarism and Central Diabetes Insipidus
Devin, J. K. (2012) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2012.06.001 · Cited by 33
Metabolomics: a tool for the diagnosis of GH deficiency and for monitoring GH replacement?
Höybye, C., Wahlstrom, E. H., Tollet‐Egnell, P., & Norstedt, G. (2014) · Endocrine Connections · doi:10.1530/ec-14-0098 · Cited by 32
Tritos, N. A., Johannsson, G., Korbonits, M., Miller, K. K., Feldt-Rasmussen, U., Yuen, K. C. J., King, D., Mattsson, A. F., Jonsson, P. J., Koltowska-Haggstrom, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1013 · Cited by 31
Wagenmakers, M. A. E. M., Roerink, S. H. P. P., Gil, L., Plantinga, T. S., Smit, J. W. A., Netea-Maier, R. T., & Hermus, A. R. (2014) · Clinical Endocrinology · doi:10.1111/cen.12639 · Cited by 35
Growth hormone deficiency and human immunodeficiency virus
Rochira, V., & Guaraldi, G. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.02.006 · Cited by 34
Yang, H., Yan, K., Xu, Y., Zhang, Q., Wang, L., Gong, F., Zhu, H., Xia, W., & Pan, H. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0711 · Cited by 32
Growth Hormone Treatment and Cancer Risk
Banerjee, I., & Clayton, P. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.11.007 · Cited by 31
Quality of Life in Growth Hormone Deficiency and Acromegaly
Webb, S. M., & Badia, X. C. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.11.011 · Cited by 32
Inzaghi, E., & Cianfarani, S. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00034 · Cited by 33
Gardner, C. J., Javadpour, M., Stoneley, C., Purthuran, M., Biswas, S., Daousi, C., MacFarlane, I. A., & Cuthbertson, D. J. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0849 · Cited by 30
Boguszewski, M. C. D. S., Boguszewski, C., Chemaitilly, W., Cohen, L. E., Gebauer, J., Higham, C., Hoffman, A. R., Polak, M., Yuen, K. C. J., Alos, N., et al. (2022) · Yearbook of pediatric endocrinology · doi:10.1530/ey.19.9.1 · Cited by 30
Kacheva, S., Kolk, K. S., Morgenthaler, N. G., Brabant, G. E., & Karges, W. (2014) · Clinical Endocrinology · doi:10.1111/cen.12608 · Cited by 31
Classical and non-classical causes of GH deficiency in adults
Tanrıverdi, F., & Keleştimur, F. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.02.001 · Cited by 36
The Endocrine System and the Heart: A Review
Rhee, S. S., & Pearce, E. N. (2011) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2010.10.016 · Cited by 45
Neto, L. V., Boguszewski, C. L., de Araújo, L. A., Bronstein, M. D., Miranda, P. A. C., Musolino, N. R. D. C., Naves, L. A., Vilar, L., Ribeiro‐Oliveira, A., & Gadelha, M. R. (2016) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000179 · Cited by 35
Penta, L., Cofini, M., Lucchetti, L., Zenzeri, L., Leonardi, A., Lanciotti, L., Galeazzi, D., Verrotti, A., & Esposito, S. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16030307 · Cited by 31
“Although the insulin tolerance test (ITT) is recommended for retesting because it investigates both GH secretion and hypothalamus-pituitary-adrenal axis function [37,38], this test can induce severe side effects and is contraindicated in some patients [2,39]; therefore, the glucagon test and”
BackgroundAdult Growth Hormone Deficiency: Current Concepts
Fukuda, I., Hizuka, N., Muraoka, T., & Ichihara, A. (2014) · Neurologia medico-chirurgica · doi:10.2176/nmc.ra.2014-0088 · Cited by 35
The Rational Use of Pituitary Stimulation Tests
Petersenn, S., QUABBE, H.-J., Schöfl, C., Stalla, G. K., von Werder, K., & Buchfelder, M. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0437 · Cited by 47
Focus on growth hormone deficiency and bone in adults
Tritos, N. A. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.02.002 · Cited by 35
Suzuki, A., Sekiguchi, S., Asano, S., & Itoh, M. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fm0070218 · Cited by 38
Bellone, S., Einaudi, S., Caputo, M., Prodam, F., Busti, A., Belcastro, S., Parlamento, S., Zavattaro, M., Verna, F., Bondone, C., et al. (2013) · Pituitary · doi:10.1007/s11102-012-0446-0 · Cited by 28
The Oxytocin System and Implications for Oxytocin Deficiency in Hypothalamic-Pituitary Disease
Aulinas, A., & Lawson, E. A. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf008 · Cited by 34
Update on GH therapy in adults
Boguszewski, C. L. (2017) · F1000Research · doi:10.12688/f1000research.12057.1 · Cited by 29
Bonert, V. S., Carmichael, J. D., Wu, Z. R., Mirocha, J., Perez, D. A., Clarke, N. J., Reitz, R. E., McPhaul, M. J., & Mamelak, A. N. (2017) · Pituitary · doi:10.1007/s11102-017-0849-z · Cited by 30
A Suggested Role of Human Growth Hormone in Control of the COVID-19 Pandemic
Elkarow, M. H., & Hamdy, A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.569633 · Cited by 34
Hörenz, C., Vogel, M., Wirkner, K., Ceglarek, U., Thiery, J., Pfäffle, R. W., Kieß, W., & Kratzsch, J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac157 · Cited by 29
Growth Hormone: The Expansion of Available Products and Indications
Franklin, S. L., & Geffner, M. E. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2009.06.006 · Cited by 29
Quigley, C. A., Zagar, A. J., Liu, C. C., Brown, D. M., Huseman, C. A., Levitsky, L. L., Repaske, D. R., Tsalikian, E., & Chipman, J. J. (2013) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2013-6 · Cited by 31
Diri, H., Karaca, Z., Şimşek, Y., Tanrıverdi, F., Ünlühızarcı, K., Selçuklu, A., & Keleştimur, F. (2015) · Pituitary · doi:10.1007/s11102-015-0666-1 · Cited by 31
“ITT has been regarded as the gold-standard test for the diagnosis of GHD, because induced hypoglycemia is considered a powerful stimulator of GH release [6, 7].”
BackgroundMethodResultInfluentialTransitioning of children with GH deficiency to adult dosing: changes in body composition
Nguyen, V. T., & Misra, M. (2008) · Pituitary · doi:10.1007/s11102-008-0101-y · Cited by 28
Woodmansee, W. W., Hartman, M. L., Lamberts, S. W. J., Zagar, A. J., Clemmons, D. R., & on behalf of the International HypoCCS Advisory Board (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03612.x · Cited by 29
Self-citationChallenges of insulin-like growth factor-1 testing
Huang, R., Shi, J., Wei, R., & Li, J. (2024) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2024.2306804 · Cited by 37
“To minimize these complicated factors, the use of IGF-1 SDS has emerged for assessing IGF-1 levels [45,46].”
Roerink, S. H. P. P., Wagenmakers, M. A. E. M., Wessels, J. F., Sterenborg, R. B. T. M., Smit, J. W. A., Hermus, A. R. M. M., & Netea-Maier, R. T. (2014) · Pituitary · doi:10.1007/s11102-014-0583-8 · Cited by 31
Rutter, M. M., Wong, B. L. Y., Collins, J. J., Sawnani, H., Taylor, M. D., Horn, P. S., & Backeljauw, P. F. (2020) · Muscle & Nerve · doi:10.1002/mus.26846 · Cited by 27
Pituitary Apoplexy: A Retrospective Study of 33 Cases From a Single Center
Falhammar, H., Tornvall, S., & Höybye, C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.656950 · Cited by 27
Karamouzis, I., Pagano, L., Prodam, F., Mele, C., Zavattaro, M., Busti, A., Marzullo, P., & Aimaretti, G. (2015) · Endocrine · doi:10.1007/s12020-015-0796-2 · Cited by 28
“The somatotroph (GH-IGF-I) axis needs to be evaluated by stimulation test, unless all other pituitary axes are deficient and insulin-like growth factor-1 (IGF-1) is low [1, 55, 56].”
BackgroundChikani, V., Cuneo, R. C., Hickman, I. J., & Ho, K. K. Y. (2016) · Clinical Endocrinology · doi:10.1111/cen.13147 · Cited by 30
Gasco, V., Prodam, F., Grottoli, S., Marzullo, P., Longobardi, S., Ghigo, E., & Aimaretti, G. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0563 · Cited by 30
Okamoto, K., Koda, M., Okamoto, T., Onoyama, T., Miyoshi, K., Kishina, M., Matono, T., Kato, J., Tokunaga, S., Sugihara, T., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0219412 · Cited by 28
van Varsseveld, N. C., van Bunderen, C. C., Franken, A. A. M., Koppeschaar, H. P. F., van der Lely, A. J., & Drent, M. L. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1764 · Cited by 26
Meienberg, F., Yee, M. S., Johnston, D. G., Cox, J., Robinson, S., Bell, J. D., Thomas, E. L., Taylor-Robinson, S. D., & Godsland, I. F. (2016) · Clinical Endocrinology · doi:10.1111/cen.13042 · Cited by 27
Lithgow, K., Chin, A., Debert, C. T., & Kline, G. A. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0247-1 · Cited by 26
Growth Hormone Therapy in Heart Failure
Salzano, A., Marra, A. M., D’Assante, R., Arcopinto, M., Suzuki, T., Bossone, E., & Cittadini, A. (2018) · Heart Failure Clinics · doi:10.1016/j.hfc.2018.05.002 · Cited by 26
Metadata
- Authors
- Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L.
- Affiliations
- Northwestern University (US)
- University of North Carolina at Chapel Hill (US)
- University of Washington (US)
- University of Virginia (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-06
- Volume
- 96
- Issue
- 6
- Pages
- 1587-1609
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2090627812
- Semantic Scholar
- 82180f0f73f275a6a0e865c2c46af465e9dc1fc8
- Cited by
- 1,047
- References
- 207
- Citations by year
- 2026: 31 · 2025: 43 · 2024: 46 · 2023: 53 · 2022: 59 · 2021: 61 · 2020: 59 · 2019: 59 · 2018: 64 · 2017: 56 · 2016: 66 · 2015: 63 · 2014: 61 · 2013: 75 · 2012: 42
- FWCI
- 57.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- adult growth hormone deficiency, growth hormone therapy, body composition, exercise capacity, skeletal integrity, quality of life, treatment risks and benefits
- MeSH terms
- Adult, Dwarfism, Pituitary, Humans, Evidence-Based Medicine, Human Growth Hormone, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.